Heart valve disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Long-term warfarin anticoagulation is required after heart valve replacement surgery.
Exclusion criteria
Exclusion criteria: 1.Patients who were unable to comply with and cooperate with this study. 2.Patients with severe liver and kidney insufficiency, cardiac insufficiency, massive gastrointestinal bleeding or stroke and other neurological disorders, and those with relative contraindications to anticoagulation. 3.Other circumstances where the researcher, based on professional judgment, deems the patient unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Warfarin anticoagulation time compliance rate (TTR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Clinical Compliance Rate;The usage of warfarin;Symptomatic thromboembolic events;Major bleeding related to anticoagulation; | — |
Countries
China
Contacts
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine